GSK plc Profile Avatar - Palmy Investing

GSK plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United …
Drug Manufacturers - General
GB, Brentford [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million GBP. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
7,841.00 6,797.00 6,250.00 4,375.00 7,222.00 5,176.00 2,569.00 6,497.00 6,918.00 8,421.00 8,020.00 8,441.00 7,952.00 7,403.00 6,348.00
Operating Cash (Net)
7,841.00 6,797.00 6,250.00 4,375.00 7,222.00 5,176.00 2,569.00 6,497.00 6,918.00 8,421.00 8,020.00 8,441.00 7,952.00 7,403.00 6,348.00
Accounts Receivable
- - - - - - 183.00 16.00 347.00 98.00 193.00 -213.00 -411.00 -192.00 -383.00 -1,162.00 -616.00 -649.00
Accounts Payable
- - - - - - - - - - - - - - 96.00 11.00 131.00 263.00 225.00 229.00 494.00 -15.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-4,013.00 -1,868.00 -112.00 -2,631.00 524.00 -1,078.00 6,037.00 -1,269.00 -1,443.00 -1,553.00 -5,354.00 2,161.00 -1,777.00 -8,772.00 -1,934.00
Capital Expenditure
-1,873.00 -1,635.00 -1,328.00 -1,520.00 -1,701.00 -1,751.00 -1,901.00 -2,352.00 -2,202.00 -1,796.00 -2,163.00 -2,239.00 -2,931.00 -2,258.00 -2,344.00
Purchases of Investments
-183.00 -340.00 -111.00 224.00 15.00 1.00 -2.00 -928.00 4.00 -309.00 -258.00 -1.00 1,759.00 -144.00 -123.00
Sale/Maturity of Investment
324.00 118.00 30.00 28.00 59.00 205.00 357.00 683.00 4.00 -452.00 1.00 3,269.00 18.00 1.00 1,905.00
Property, Plant, Equipment (P&PE)
-1,873.00 -1,635.00 -1,328.00 -1,520.00 -1,701.00 -1,751.00 -1,901.00 -2,352.00 -2,202.00 -1,796.00 -2,163.00 -2,239.00 -2,931.00 -2,258.00 -2,344.00
Acquisitions (Net)
-2,792.00 -354.00 727.00 -2,535.00 1,951.00 235.00 7,528.00 592.00 356.00 -292.00 -3,780.00 3,008.00 185.00 -3,136.00 -1,384.00
Other Investing Activities
511.00 343.00 570.00 1,172.00 200.00 232.00 55.00 736.00 395.00 1,296.00 846.00 -1,876.00 -808.00 -3,235.00 12.00
Financing Activities
Used Cash (Net)
-2,774.00 -5,571.00 -6,232.00 -3,351.00 -6,273.00 -5,385.00 -7,103.00 -6,392.00 -6,380.00 -6,389.00 -1,840.00 -10,132.00 -7,589.00 -823.00 -4,882.00
Debt Repayment
-796.00 -1,341.00 -8.00 -2,559.00 -1,872.00 -1,709.00 -2,412.00 -919.00 -3,200.00 -1,986.00 -4,580.00 -7,305.00 -1,995.00 -4,622.00 -2,370.00
Dividends Paid
-3,092.00 -3,205.00 -3,406.00 -3,814.00 -3,680.00 -3,843.00 -3,874.00 -4,850.00 -3,906.00 -3,927.00 -3,953.00 -3,977.00 -3,999.00 -3,467.00 -2,247.00
Common Stock
115 95 2,522 2,944 2,134 500 172 163 121 -8,700 - - -970 1,664 - - 207
Other Financing Activities
1,115.00 -1,088.00 -886.00 5,138.00 243.00 333.00 -791.00 -638.00 735.00 -9,324.00 -2,467.00 122.00 27.00 8,887.00 -78.00
Cash Balances
Begin of Period
5,472.00 6,368.00 5,807.00 5,605.00 3,906.00 5,231.00 4,028.00 5,486.00 4,605.00 3,600.00 4,087.00 4,831.00 5,262.00 3,819.00 3,723.00
End of Period
6,368.00 6,057.00 5,605.00 3,906.00 5,231.00 4,028.00 5,486.00 4,605.00 3,600.00 4,087.00 4,831.00 5,262.00 3,819.00 3,425.00 2,936.00
Change
896.00 -311.00 -202.00 -1,699.00 1,325.00 -1,203.00 1,458.00 -881.00 -1,005.00 487.00 744.00 431.00 -1,443.00 -394.00 -787.00
Non-Cash Balances
Depreciation and Amortization
1,271.00 2,071.00 1,677.00 1,085.00 1,415.00 2,026.00 1,862.00 1,861.00 2,981.00 1,763.00 2,996.00 624.00 2,524.00 2,298.00 2,294.00
Stock Based Compensation
179.00 179.00 198.00 220.00 319.00 332.00 368.00 319.00 333.00 360.00 365.00 337.00 343.00 346.00 307.00
Other
2,935.00 1,938.00 709.00 729.00 706.00 659.00 653.00 664.00 669.00 717.00 814.00 848.00 756.00 351.00 540.00
Highlighted metrics
Free Cash Flow (FCF)
5,968.00 5,162.00 4,922.00 2,855.00 5,521.00 3,425.00 668.00 4,145.00 4,716.00 6,625.00 5,857.00 6,202.00 5,021.00 5,145.00 4,004.00
Cash Conversion Cycle (CCC)
-49.00 -71.00 -173.00 -132.00 -133.00 -129.00 -126.00 -192.00 -472.00 -230.00 -199.00 -229.00 -284.00 -336.00 160.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of GSK's Analysis
CIK: 1131399 CUSIP: 37733W204 ISIN: US37733W2044 LEI: - UEI: -
Secondary Listings